🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ticagrelor is a potent and fast-acting P2Y12-ADP receptor antagonist recomm...
Status
Completed
Location
APHM
Start Date
2018-10-28
Trial ID
NCT03357874
Treatments Being Tested
The primary objective of this study is to assess the pharmacodynamic (PD) e...
Status
Completed
Location
Biotrial Inc
Start Date
2018-01-24
Trial ID
NCT03430661
Treatments Being Tested
REL-0609 trial's hypothesis is that repeated loading doses of clopidogrel (...
Status
Withdrawn
Location
Krakowskie Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii Carint Scanmed Sp. z o.o
Start Date
2012-03
Trial ID
NCT01636180
Treatments Being Tested
Although prasugrel, recently available thienopyridine derivative, exhibits ...
Status
Completed
Location
DongA University Hospital
Start Date
2011-12
Trial ID
NCT02070159
Treatments Being Tested
The hypothesis of this study is that Stress-MRI is a clinically significant...
Status
Completed
Location
State Research Institute of CIrculation Pathology
Start Date
2010-10
Trial ID
NCT02769650
Treatments Being Tested
Clopidogrel is the P2Y12 inhibitor of choice in PCI patients requiring OAC....
Status
Completed
Location
University of Florida
Start Date
2020-12-08
Trial ID
NCT04483583
Treatments Being Tested
There are two separate objectives in this study: 1. To demonstrate the pha...
Status
Completed
Location
Fletcher Allen Health Care
Start Date
2013-12-02
Trial ID
NCT01979445
Treatments Being Tested
Context: Soluble CD40 ligand (sCD40L) released from activated platelets ind...
Status
Completed
Location
University of Cologne
Start Date
2005-01
Trial ID
NCT01112137
Treatments Being Tested
Ticagrelor, a new P2Y12 receptor antagonist, achieve faster, consistent and...
Status
Unknown
Location
Shenyang Northern Hospital
Start Date
2015-10
Trial ID
NCT02578537
Treatments Being Tested
The purpose of this study is to provide information of the relative potency...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2006-08
Trial ID
NCT00357968
Treatments Being Tested